Arcus Biosciences, Inc. (RCUS) Q2 2026 Earnings Call Transcript

SA Transcripts 161.55K Followers Follow Arcus Biosciences, Inc. ( RCUS ) Q2 2026 Earnings Call August 5, 2026 4:30 PM EDT Company Participants Pia Eaves - Vice President of Investor Relations & Strategy Terry Rosen - Co-Founder, Chairman & CEO Richard Markus - Chief Medical Officer Juan Jaen - Co- Founder & President Robert Goeltz - Principal Financial Officer & CFO Conference Call Participants Salim Syed - Mizuho Securities USA LLC, Research Division Daina Graybosch - Leerink Partners LLC, Research Division Jonathan Miller - Evercore ISI Institutional Equities, Research Division Li Wang Watsek - Cantor Fitzgerald & Co., Research Division Presentation Operator Hello, everyone. Thank you for joining us and welcome to the Arcus' Second Quarter 2026 Earnings Call. After today's prepared remarks, we will host a question-and-answer session. [Operator Instructions] I will now hand the conference over to Pia Eaves, Vice President of Investor Relations. Pia, please go ahead. Pia Eaves Vice President of Investor Relations & Strategy Good afternoon, and thank you for joining us on today's conference call to discuss Arcus' second quarter 2026 financial results and pipeline updates. I'd like to remind you that on this call, management will make forward-looking statements, including statements about our development strategies and our expectations regarding advantages and opportunities afforded by our investigational products, our clinical development milestones and timelines, our projected cash runway, and our financial outlook. All statements other than historical facts reflect the current beliefs and expectations of management and involve risks and uncertainties that may cause our actual results to differ from those expressed. Those risks and uncertainties are described in our most recent quarterly report on Form 10-Q that has been filed with the SEC. For today's call, please refer to our latest corporate presentation posted in the Investors section of our website. This afternoon, you'll hear from our CEO, Terry Rosen, CMO, Richard Markus, President Juan Jaen, and CFO, Bob Goeltz. With that, I'll turn the call